CPI SPRINT WORKSHOP: Technologies to accelerate the development of novel therapeutics

Event Details

Start Date
Mon, 15 Nov 2021
End Date
Tue, 16 Nov 2021
Funded by
Share This Page
Events

• Are you developing a biological novel therapeutic or working with companies that do?
• Would you like to increase your knowledge of this area or access support for your product development?
• Would you like to provide some continuing professional development for your staff?

CPI is delivering a new ERDF Project, SPRINT (Supporting Process Innovation for Novel Therapies) across the Cambridge and Peterborough Combined Authority (CPCA) region to support and accelerate the commercialisation of Novel Biological Instrumentation, Products, and Therapeutics.

As part of the programme, we are pleased to announce an interactive, two-day workshop on the 15th and 16th of November, at a venue in the CPCA region (to be confirmed) and will be fully funded (worth around £1,000 per attendee) for eligible SMEs from the CPCA region. There will be a small group of participants encouraging interactions with the technical experts and fellow attendees.

Companies eligible for this workshop:

  • should be developing novel biotherapeutics or products and services within this field wanting to upskill or provide refresher training for their workforce.
  • need to be SMEs located in the CPCA region.

The workshop will provide an opportunity to receive in-depth understanding of the biologics capabilities at CPI and how these can help your organisation progress your innovation to market. The programme will consist of presentations by CPI technical experts, followed by questions and answers. There will also be a two-hour 1:1 confidential deep dive with CPI technical experts to identify further support for the SME, for example a collaborative project funded by SPRINT.

Agenda

    • Considerations in scale up of synthetic expression processes, Jade Tuck, Senior Scientist — Upstream, Synthetic biology,
    • Expression system options and selection for development and scale up, Philip Probert, Head of Technical
    • Strategies for maximising value from high-throughput development runs, Suzanne Robb, Senior Scientist – Upstream / Technology and Innovation Officer
    • Considerations for developing a safe and stable formulation, Andrew Bright, Team Leader — Formulation and Fill Finish
    • The basics of freeze-drying, Andrew Bright, Team Leader — Formulation and Fill Finish
    • Establishing robustness of downstream processes/​unit operations, John Liddell, Chief Technologist
    • Using high-throughput screening for downstream process development, Laura Russell, Team Leader- High Throughput Development, Downstream Processing
    • How high-throughput analytics can help process characterisation, Nic Farrands, Manager — Analytical and Formulation
    • Next generation analytical tools for biopharmaceutical characterisation, Clare Trippett, Chief Technologist
    • Process analytical technologies for the manufacturing of biologics, Daniel Myatt, Senior Scientist — Analytical Characterisation, Analytical
    • Data Analytics for Biopharmaceutical Processing, Lukas Kuerten, Senior Scientist – Data Analytics

Please note, this workshop has a limited number of slots available, therefore places will be given on a first come, first served basis.

Register your interest for this workshop by filling out the form below.

ERDF SPRINT programme: https://​www​.uk​-cpi​.com/​s​print.